Zentalis Pharmaceuticals (ZNTL) Other financing activities (2019 - 2024)
Zentalis Pharmaceuticals' quarterly Other financing activities came in at $241000.0 in Q1 2024, up 162.44% quarter-over-quarter from -$386000.0 in Q3 2021.
Zentalis Pharmaceuticals has reported Other financing activities for 4 years, with the latest figure at $241000.0 in Q1 2024.
- For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $241000.0; the trailing twelve-month figure through Sep 2024 stood at $241000.0 (changed N/A YoY), and the FY2020 full-year result was $18.4 million, up 39952.17% from the prior year.
- Other financing activities for Q1 2024 stood at $241000.0, up from -$386000.0 in the prior quarter.
- The five-year high for Other financing activities was $18.4 million in Q3 2020, with the low at -$754000.0 in Q2 2020.
- Average Other financing activities over 3 years is $3.1 million, with a median of $313500.0 recorded in 2021.
- Peak annual rise in Other financing activities reached 151.19% in 2021, while the deepest fall reached 102.1% in 2021.
- Tracing ZNTL's Other financing activities over 3 years: stood at $18.4 million in 2020, then plunged by 102.1% to -$386000.0 in 2021, then jumped by 162.44% to $241000.0 in 2024.
- The last three Other financing activities figures came in at $241000.0 (Q1 2024), -$386000.0 (Q3 2021), and $386000.0 (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 241,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Sep 30, 2021 | -386,000.00 |
| Sep 30, 2021 | -386,000.00 |
| Jun 30, 2021 | 386,000.00 |
| Jun 30, 2021 | 386,000.00 |
| Sep 30, 2020 | 18.42 Mn |
| Sep 30, 2020 | 18.42 Mn |
| Jun 30, 2020 | -754,000.00 |
| Jun 30, 2020 | -754,000.00 |
| Mar 31, 2020 | 754,000.00 |
| Mar 31, 2020 | 754,000.00 |
| Dec 31, 2019 | 46,000.00 |
| Dec 31, 2019 | 46,000.00 |